Home Podcasts Investors' Chronicle
Investors' Chronicle

Investors' Chronicle

Investors' Chronicle 1157 Episodes Sep 18, 2026

Investors' Chronicle is a podcast that explores key trends in the financial markets and offers insights for private investors. It features exclusive interviews with professional investors, fund managers, and financial experts. The show aims to help listeners make smarter investment decisions by highlighting rewarding opportunities. With over 160 years of history, Investors' Chronicle is a trusted source for investment research and analysis in the UK.

Episodes

McBride, Supermarket Income Reit and AI threats
McBride, Supermarket Income Reit and AI threats Sep 18, 2026 33:50 This week’s episode looks at two companies making a series of deals and partnerships in a bid to buck the troubling trends in their respective sectors. We begin with consumer staples company McBride, whose shares have been buoyant in recent weeks as the cleaning products manufacturer, known for brands such as Oven Pride, expands its horizons. Mark Robinson is in the studio to discuss the deta
Back to basics: How to build a portfolio
Back to basics: How to build a portfolio Sep 15, 2026 28:04 Figuring out which funds to buy is overwhelming for even the most experienced investors – but as a beginner, it’s important to understand your options so you can make the right decisions. Funds editor Val Cipriani is in the studio with personal finance editor Holly McKechnie to break down the process. First, the duo explains what a fund is, the three main types, and why they are a good option
Semiconductor stocks, our Top 50 Funds and Mortgage Advice Bureau: Companies and Markets Show
Semiconductor stocks, our Top 50 Funds and Mortgage Advice Bureau: Companies and Markets Show Sep 11, 2026 37:07 Even as uncertainty reins in the markets, 2026 has been another bumper year for returns. But, as ever, that does hide plenty of dispersion below the surface; with that in mind, this week’s show looks at two stocks at opposite ends of the scale.One is up over 800 per cent in the year to date – that’s semiconductor manufacturer IQE, which reported interim results on Monday. Michael Fahy is in the st
Our favourite ETFs, toxic stocks to avoid and industrials: Companies and Markets show
Our favourite ETFs, toxic stocks to avoid and industrials: Companies and Markets show Sep 4, 2026 38:38 This week’s show begins with a look at Meta after the social media giant had to fork out $18bn following accusations that its products are deliberately addictive for younger people. Valeria Martinez is in the studio to discuss whether big tech and other sectors are now the new ‘sin stocks’ and whether the companies which are so irresistible to consumers are toxic for investors. We then discus
Protecting your pension, UK industrials and Nvidia: Companies and Markets Show
Protecting your pension, UK industrials and Nvidia: Companies and Markets Show Aug 28, 2026 28:34 First, we cast our ears to British industrial stocks and ask whether they are being picked off too cheaply. Michael Fahy dives into why manufacturers are significantly more undervalued than their US counterparts and discusses the sector’s acquisitions in recent years.We then turn to what is arguably our most important savings pot: the pension. You may have saved diligently and kept a close eye on
How to invest under Andy Burnham: Lee and the IC
How to invest under Andy Burnham: Lee and the IC Aug 25, 2026 44:44 After a summer hiatus, Alex Newman and Lord Lee are back in the studio, and the duo have a lot to catch up on. The UK has seen a change of prime minister, record-breaking heat and plenty of action in stock markets.First, the pair turn to Britain’s new government. While Andy Burnham and John Healey have revealed very little about their fiscal plans, Lord Lee gives his thoughts, including how to enc
JD Sports, Pershing Square’s overhaul and Oxford Nanopore:Companies and Markets Show
JD Sports, Pershing Square’s overhaul and Oxford Nanopore:Companies and Markets Show Aug 21, 2026 28:04 Up first this week is self-labelled ‘King of Trainers’ JD Sports, whose shares took a 15 per cent tumble on Thursday morning. The FTSE 100 retailer has blamed much of the slump on delayed back-to-school spending and a rising cost of living. Erin Withey explains what’s going on.Next we turn to what has become a trend of the past few months: star fund managers overhauling portfolios. Bill Ackman of
Legal & General, infrastructure stocks and GSK: Companies and Markets Show
Legal & General, infrastructure stocks and GSK: Companies and Markets Show Aug 14, 2026 26:16 After an avalanche of earnings updates, we turn to our annual Income Majors special report and dive into two prominent FTSE 100 dividend stocks. First up is insurer Legal & General; pressure has been mounting on the company as it grapples with a more competitive pensions market. Christopher Akers explains the CEO’s buyback plan, its yield and what it means for investors.We then move to GSK, on
How to defeat the gender wealth gap
How to defeat the gender wealth gap Aug 11, 2026 27:44 Women, on average, earn less than men, have less saved in a pension and have to take more time off from work to care for others. But while society is rigged to burden women with heavier loads, Gina Miller has made it her mission to change this and close the gender wealth gap. Gina is an activist, entrepreneur and the founder of MoneyShe, an investment platform focused on women’s finances. Gin
The AI jobs crunch, medical stocks and AstraZeneca: Companies and Markets Show
The AI jobs crunch, medical stocks and AstraZeneca: Companies and Markets Show Aug 7, 2026 37:40 M&A activity remains rampant, and this week we start with a tie-up that would rank among the biggest deals of all time: AstraZeneca and US rival Bristol Myers Squibb. Julian Hofmann discusses the merits of the mooted $400bn deal, the drawbacks and why investors’ response to the rumour has been bleak. We then turn to what could be the greatest disrupter humans have seen for decades: the ri
US IPOs, Rentokil and emerging markets: Companies and Markets show
US IPOs, Rentokil and emerging markets: Companies and Markets show Jul 31, 2026 29:47 Results season is in full swing, and it’s been another bumper week – with the overwhelming majority positive. But there are always laggards, and this week’s show dives into one of the FTSE 100’s biggest fallers, Rentokil. The pest control business’s shares plunged after its half-year figures. Julian Hofmann explains why.Then, we look overseas, with many of the big AI and semiconductor trades going
‘We are the space 3i’: Mark Boggett of Seraphim Space
‘We are the space 3i’: Mark Boggett of Seraphim Space Jul 28, 2026 43:43 Seraphim Space (SSIT) has been one of the best performing investment trusts in the past year. Helped by the enthusiasm for the sector generated by SpaceX, the £400mn trust pulled off a rare fundraising and now has a pile of cash to deploy.Val Cipriani sits down with chief executive Mark Boggett, who discusses opportunities and volatility in space, why he isn’t afraid of concentration, and how spac

Recommended